Solid pharmaceutical preparation containing (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylme thylaminomethyl]chroman

Details for Australian Patent Application No. 2006261314 (hide)

Owner Merck Patent GmbH

Inventors Rupp, Roland; Heil, Kirstin; Kunath, Klaus

Agent Davies Collison Cave

Pub. Number AU-B-2006261314

PCT Pub. Number WO2006/136302

Priority 05013293.5 21.06.05 EP

Filing date 9 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 22 March 2012

International Classifications

A61K 31/4433 (2006.01)

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 February 2008 PCT application entered the National Phase

  PCT publication WO2006/136302 Priority application(s): WO2006/136302

22 March 2012 Application Accepted

  Published as AU-B-2006261314

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261316-Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them

2006261309-Methods and systems for adding a reagent to an analyte in a gel